A phase 2, randomized trial of GVAX pancreas and CRS-207 immunotherapy versus GVAX alone in patients with metastatic pancreatic adenocarcinoma: Updated results.

@article{Le2014AP2,
  title={A phase 2, randomized trial of GVAX pancreas and CRS-207 immunotherapy versus GVAX alone in patients with metastatic pancreatic adenocarcinoma: Updated results.},
  author={Dung T Le and Andrea Wang-Gillam and Vincent J. Picozzi and Tim F Greten and Todd S Crocenzi and Gregory M. Springett and Michael Andew Morse and Herbert J. Zeh and Deirdre Jill Cohen and Robert L. Fine and Beth Onners and Jennifer N. Uram and Daniel A. Laheru and Aimee Luck Murphy and Justin Skoble and Ed Lemmens and John J. Grous and Thomas W Dubensky and Dirk G. Brockstedt and Elizabeth M Jaffee},
  journal={Journal of Clinical Oncology},
  year={2014},
  volume={32},
  pages={177-177}
}

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS

Future approaches in immunotherapy.

  • Seminars in oncology
  • 2014
VIEW 3 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Similar Papers

Loading similar papers…